Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute lymphoblastic leukemia with pre-B-cell characteristics.

J C Brouet, J L Preud'homme, C Penit

    Blood
    |July 1, 1979
    PubMed
    Summary

    Researchers identified a new subgroup of acute lymphoblastic leukemia (ALL) in pre-B cells, characterized by specific protein markers. Further studies are needed to determine the prognostic significance of this finding in non-T, non-B ALL patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Two Cases of Translocation t(3;6)(p14;p22): A Non Random Chromosomal Abnormality?

    Leukemia & lymphoma·2016
    Same author

    [Acute megakaryoblastic leukemia (AML-7) in a woman of 95 years].

    Annales de biologie clinique·2006
    Same author

    [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].

    Dakar medical·2005
    Same author

    DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.

    Leukemia·2005
    Same author

    IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRgammadelta phenotype and absence of IL7Ralpha/CD127 expression.

    Leukemia·2004
    Same author

    Plasma-cell leukemia and human herpesvirus 8 infection.

    Leukemia·2004

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Acute lymphoblastic leukemia (ALL) is a heterogeneous disease.
    • Subclassification of ALL is crucial for understanding its biology and prognosis.
    • Identifying novel ALL subtypes can lead to improved diagnostic and therapeutic strategies.

    Purpose of the Study:

    • To characterize a distinct subgroup of acute lymphoblastic leukemia (ALL) identified by specific cellular markers.
    • To investigate the potential relationship of these ALL cells to early B-cell precursors (pre-B cells).
    • To assess the clinical presentation and potential prognostic implications of this newly identified ALL subgroup.

    Main Methods:

    • Flow cytometry analysis of blast cells from ALL patients.
    • Detection of intracytoplasmic mu chains, light chains, and surface immunoglobulins.

    Related Experiment Videos

  • Immunophenotyping for common ALL antigens and TdT (terminal deoxynucleotidyltransferase) expression.
  • Clinical data review, including disease presentation.

    • Main Results:

    • Six out of 50 (12%) ALL patients exhibited blast cells with intracytoplasmic mu chains but no detectable light chains or surface immunoglobulins.
    • These cells co-expressed common ALL antigens and TdT was detected in 2 of 5 cases.
    • The blast cells are likely related to early B-cell precursors (pre-B cells).
    • A tumoral presentation was observed in 4 of these 6 cases.

    Conclusions:

    • A novel subgroup of non-T, non-B ALL, representing approximately 20% of cases, has been identified.
    • This subgroup is characterized by pre-B cell immunophenotype.
    • The prognostic significance of this pre-B cell ALL subgroup requires further investigation.